$VKTX something not right with all market , tech and biotech. Actually unlike last 2 years VK been more stable than rest of biotech. Cant believe 105 trial sites and no leaks. But still wonder if investors see VK as future cash pay cow that would survive under any geopolitical / bubble pop scenario ..or even changes in health care
View on X ↗